Case Report: Efficacy and safety of dose-escalated Mazdutide, a GLP-1/GCGR dual agonist, in an adolescent with obesity, type 2 diabetes, and hyperuricemia. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.